Arrowhead Research | ARWR - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Anika Therapeutics 47.54 27.2 2024-06
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ligand Pharmaceuticals 56.5 26.8 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Novartis 20.17 2.32 2026-03
Sarepta Therapeutics 27.27 0 2025-12
TG Therapeutics 10.76 2.32 2025-12
Vertex Pharmaceuticals 25.82 0.33 2026-03
Xencor 29.92 3.22 2022-09